Spleen precise expression composition, vaccine composition and their applications

TW202639145APending Publication Date: 2026-10-01RINUAGENE BIOTECHNOLOGY CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114147852
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-05
Filing Date
2025-12-05
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078707_001
    Figure TWG2TA001078707_001
  • Figure TWG2TA001078707_002
    Figure TWG2TA001078707_002
  • Figure TWG2TA001078707_003
    Figure TWG2TA001078707_003
Patent Text Reader

Abstract

A lipid nanoparticle composition that is easily enriched in the spleen; the spleen precise expression composition can be used to prepare lipid nanoparticles or drug or vaccine composition, and can be efficiently delivered to the spleen, its tissues, and cells, significantly reducing the expression of target genes in non spleen organs and avoiding side effects caused by unexpected expression, such as inflammatory reactions or other off target effects.
Need to check novelty before this filing date? Find Prior Art